1. Chemosensitivity study of urological malignancies using a novel dye-exclusion method

   • Katsusuke Naito
   • haruo Hisazumi
   • Tadao Uchibayashi

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S1 - S5

2. Intra-arterial chemotherapy for bladder cancer

   • Shori Kanoh
   • Ryosuke Noguchi
   • Ryuichi Kitagawa

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S6 - S9

3. The role of preoperative intra-arterial doxorubicin chemotherapy in combination with low-dose irradiation for bladder cancer

   • Takeshi Uyama
   • Shoosuke Moriwaki
   • Jiro Fujita

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S10 - S14

4. Preoperative one-shot intra-arterial infusion chemotherapy for bladder cancer

   • Hiroshi Kakizaki
   • Hitoshi Suzuki
   • Kiichi Suzuki

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S15 - S19

5. Three-drug combination chemotherapy for advanced urothelial tract carcinoma

   • Shinichi Ohshima
   • Yoshinari Ono
   • Yoshio Aso

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S20 - S23

6. Adjuvant chemotherapy for invasive bladder cancer

   • Yasunari Uekado
   • Toshiaki Shinka
   • Tadashi Ohkawa

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S24 - S28

7. Adjuvant chemotherapy for uroepithelial transitional cell carcinoma

   • Manabu Kuriyama
   • Toshimi Takeuchi
   • Tsuneo Nishiura

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S29 - S33

8. Postoperative systemic adjuvant chemotherapy for bladder cancer

   • Hisakazu Kiyohara
   • Masao Kuroda
   • Toshihiko Kotake

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S34 - S38

9. The chemotherapy of advanced bladder cancer

   • Donald W. W. Newling
   • Gerrit Stoter
   • Members of the EORTC GU Tract Cooperative Group

   The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S39 - S43

10. Phase III trial of The Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder

    • Akio Maru
    • Hideyuki Akaza
    • The Japanese Urological Cancer Research Group for Adriamycin

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S44 - S48

11. Size and location of tumors influencing the effect of bladder instillation therapy

    • Hiroki Watanabe
    • Masahiro Nakao
    • Hitoshi Takada

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S49 - S51

12. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors

    • Iwao Fukui
    • Hideaki Sekine
    • Hiroyuki Oshima

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S52 - S55

13. Preoperative doxorubicin instillation in recurrent superficial bladder cancer

    • Yoshinobu Kubota
    • Sumio Noguchi
    • Shuji Fukushima

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S56 - S59

14. Intravesical chemotherapy

    • Tsuneaki Obama
    • Yosuke Matsumura
    • Okayama Urological Cancer Collaborative Group (OUCCG)

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S60 - S62

15. Approaches to the treatment of bladder cancer at Stanford

    • Frank M. Torti

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S63 - S66

16. Current status of intravesical chemotherapy trials in the EORTC Urological Group. An Overview

    • L. Denis
    • C. Bouffioux
    • Members of the EORTC Urological Group

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S67 - S71

17. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer

    • Tomoyasu Tsushima
    • Yosuke Matsumura
    • Okayama Urological Cancer Collaborating Group (OUCCG)

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S72 - S76

18. Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C

    • Shigeo Isaka
    • Tatsuya Okano
    • Yutaka Kitamura

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S77 - S80

19. Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results

    • Toyofumi Ueda
    • Atsushi Iguchi
    • The Kyushu University Urological Oncology Group

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S81 - S84

20. Prophylactic treatment for superficial bladder cancer following transurethral resection

    • Yoshihiko Hirao
    • Eigoro Okajima
    • Shuji Watanabe

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S85 - S90

21. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer

    • Hideyuki Akaza
    • Shigeo Isaka
    • The Japanese Urological Cancer Research Group for Adriamycin

    The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S91 - S96